Iovate Health Sciences USA Inc. was hit with a new proposed class suit alleging it illegally marketed HydroxyCut weight loss and workout supplements.
The HydroxyCut products lack the disclaimer that allows dietary supplements to be sold without premarket review by the Food and Drug Administration, according to the suit, filed Monday in the U.S. District Court for the Northern District of California.
For decades, consumers have been prioritizing their health and wellness through the use of dietary supplements. Their interest “took on even greater resonance” with the Covid-19 pandemic, as “millions of American consumers” sought ways to stay healthy and ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.